DexCom Inc. Stock Falls Wednesday, Underperforms Market

Traack Technologies Inc

Change company Symbol lookup

Select an option...

TRAA Traack Technologies Inc

HRL Hormel Foods Corp

GTBP GT Biopharma Inc

UNH UnitedHealth Group Inc

BAC Bank of America Corp

WSO Watsco Inc

LITB LightInTheBox Holding Co Ltd

CVCY Central Valley Community Bancorp

AFAQU AF Acquisition Corp

HCIIW Hudson Executive Investment Equity II Warrant Exp 31 Jan 2027 *W EXP 01/31/2027

Health Care : Pharmaceuticals |

Company profile

Traack Technologies Inc., formerly Nvest Inc, is engaged in developing cutting edge wireless technologies. The Company develops cutting edge wireless technologies for the Internet of things (IoT), Industrial Internet of Things (IIoT), low power wide area (LPWA), low power sensor to satellite (LP-S2S), real time location systems (RTLS) markets. It offers its products and applications for supply chain management, freight logistics, and asset tracking, monitoring, and recovery. The Company's personal tracker Traack Nano is a location-aware, anytime-anywhere Compact Autonomous Sensor Array with multiple personalities. The Company’s Traack Asset Tags provide an all-in-one solution to manage a fleet with both vehicles and equipment, by giving fleet managers critical business intelligence to stay efficient. It also provides Traack management system (TMS), which securely integrates edge devices, network, and cloud application programming interface (API) into a single solution.

DexCom Inc. Stock Falls Wednesday, Underperforms Market

4:50 pm ET January 26, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of DexCom Inc. (DXCM) slid 2.56% to $395.83 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.15% to 4,349.93 and Dow Jones Industrial Average falling 0.38% to 34,168.09. This was the stock's second consecutive day of losses. DexCom Inc. closed $263.62 below its 52-week high ($659.45), which the company reached on November 18th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson (JNJ) rose 0.45% to $168.38, Abbott Laboratories (ABT) fell 2.60% to $120.07, and Medtronic PLC (MDT) fell 0.08% to $104.09. Trading volume (928,990) eclipsed its 50-day average volume of 850,130.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 26, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

January 26, 2022 16:50 ET (21:50 GMT)